implantcast is a provider of specialised orthopaedic technology, and a market leader in oncology in Europe. Our 30-year heritage in the design and manufacture of orthopaedic implants, supported by the exceptional service of our experienced sales representatives has enabled us to establish strong partnerships within centers of excellence. At the heart of our product offering is the Modular Universal Tumour and Revision System (MUTARS®), a comprehensive solution with over 55,000 implantations worldwide. In this system, 350 individual implants can combine to provide complete intra-operative flexibility to our customers. MUTARS® is supported by innovative technologies such as EPORE®, Silver and TiN. Our products and technologies are designed to cater to a wide range of defects and indications across primary oncology, metastatic bone disease, revision and trauma. Partner with us for upcoming educational initiatives by reaching out to your local sales representative. Alternatively, please call us at 01213 595 989 or email at info@implantcast.co.uk

Adler UK is a subsidiary of Adler Ortho SpA, a privately owned Italian company, focused on innovative technology and specialising in the design, manufacture, marketing of orthopaedic implants. Adler were the first orthopaedic company to employ additive layer manufacturing (ALM) technology in orthopaedics, allowing production of complex 3D shapes, providing an ideal porous structure enhancing biological integration. Evidenced with our 13A* ODEP rated Fixa TiPor acetabular cup system. Alongside the widest portfolio of ALM primary implants made with Tri-Por®, Adler also offer a responsive, full custom products service, with over 15 years experience for oncological, trauma and revision indications. Utilising the advantages of ALM, Adler is fully focused on enhancing outcomes for limb salvage surgery with the Pantheon® system, improving long-term fixation and enhancing implant function, featuring our unique endosteal fixation 3D bridging collar. In the war against peri-prosthetic infection, DAC® anti-infective hydrogel provides proven prevention of biofilm, allowing surgeons to pre-coat the device with their choice of antibiotic for maximum targeted protection.

Onkos Surgical is a leader in innovative solutions for musculoskeletal oncology and complex orthopaedic procedures. With our Precision Orthopaedics approach, surgeons are better informed about patient-specific clinical challenges and are able to plan and implement a more precise reconstruction. Our personalized approach supports improved patient outcomes and experiences using the latest innovations in virtual surgical planning, 3D modeling and printing, implant design, and workflow optimization for both adult and pediatric conditions. More than 350 of the leading academic medical institutions in the US choose Onkos Surgical Precision Orthopaedics